Sohu

Switch Bio Inc, based in Boston, MA, is pioneering a sustainable approach to fertilizer production by engineering naturally occurring microbes to create living fertilizers that can be applied directly to the roots of plants. This innovative method aims to address the environmental challenges posed by traditional fossil fuel-based fertilizers, which contribute significantly to carbon emissions and pollution. By formulating these microbes into a powder, Switch Bio enables farmers to rehydrate and apply them at crop sowing, promoting nitrogen production and enhancing plant growth. This solution not only supports global agriculture but also seeks to mitigate food insecurity and the rising costs associated with conventional fertilizer manufacturing. Generated from the website

Amryt is a global biopharmaceutical company dedicated to acquiring, developing, and commercializing innovative treatments for rare and orphan diseases. With a strong and expanding portfolio of commercial and developmental assets, Amryt aims to improve the lives of patients suffering from these debilitating conditions. The company's commercial business includes four orphan disease products: Myalept (metreleptin), Mycapssa (octreotide capsules), Juxtapid (lomitapide), and Oleogel-S10 (Filsuvez). These treatments address various conditions such as leptin deficiency, acromegaly, and Homozygous Familial Hypercholesterolaemia (HoFH). Amryt also has a promising pre-clinical gene therapy candidate, AP103, which offers potential treatment for patients with Dystrophic Epidermolysis Bullosa (EB).Generated from the website